Kop Therapeutics

Sirona Biochem Corp is a Vancouver-based cosmetic ingredient and drug discovery firm renowned for its proprietary technology that focuses on stabilizing carbohydrate molecules. With a team of award-winning scientists and extensive industry experience, the company develops safer and more effective ingredients, supported by 83 approved and pending patents worldwide. The company strategically licenses its patented compounds to global industry leaders, offering up-front fees, milestone payments, and ongoing royalties. Sirona Biochem is currently commercializing its groundbreaking anti-aging and anti-wrinkle molecule, GlycoProteMim, and has developed a promising pipeline that includes solutions for skincare and antiviral applications. Generated from the website

BioHarvest Sciences Inc., based in Vancouver, BC, is a pioneering company in the field of biologics, specializing in the development and manufacturing of patentable plant-based small complex molecules through its proprietary Botanical Synthesis technology. The company addresses the growing demand for natural and sustainable health solutions, offering innovative products in the nutraceutical, pharmaceutical, and cosmeceutical sectors. Founded by Dr. Yochi Hagay and Dr. Zaki Rakib in 2007, BioHarvest has achieved significant commercial success with its flagship product, VINIA, a red grape cell-based composition that enhances nitric oxide production and improves blood circulation. With a commitment to sustainability and environmental stewardship, BioHarvest is well-positioned to meet the industry's need for clean, consistent, and novel health ingredients. Generated from the website

Defence Therapeutics Inc., headquartered in Vancouver, BC, is a leading biotechnology company focused on advancing drug delivery technologies to combat cancer and infectious diseases. Their innovative Accum Technology provides a scalable delivery platform that enhances drug efficacy by targeting infected cells with a tenfold impact compared to existing solutions. Committed to redefining treatment methodologies, Defence Therapeutics is pioneering novel cancer therapeutics and vaccine developments through proprietary platforms aimed at enhancing drug delivery across various diseases. With significant market potential and a robust collaborative framework, the company is positioned at the forefront of transformative biopharmaceutical innovations. Generated from the website